Impact of adherence to treatment with fluticasone propionate/salmeterol in asthma patients

References

• Asthma 2010. Statistics Canada. Available at: http://www.statcan.gc.ca/pub/82-625-x/2011001/article/11458-eng.htm. [Last accessed 14 February 2011]
   Google Scholar
• Chen Y, Johansen H, Thillaiampalam S, et al. Asthma. Health Rep 2004; 16:43-46
   Google Scholar
• Canadian Community Health Survey. Table 105-0501: Health indicator profile, annual estimates, by age group and sex, Canada, provinces, territories, health regions (2007 boundaries) and peer groups, occasional, 2003 to 2010. Statistics Canada. Available at: http://cansim2.statcan.gc.ca/cgi-win/cnsmcgi.exe?Lang=E&CNSM-Fi=CII/CII_1-eng.htm. [Last accessed on 31 January 31, 2011]
   Google Scholar
• Harrison BD, Pearson MG. Audit in acute severe asthma–who benefits? J R Coll Physicians Lond 1993;27:387-90
   PubMedGoogle Scholar
• Garner R, Kohen D. Changes in the prevalence of asthma among Canadian children. Health Rep 2008;19:45-50
   PubMedGoogle Scholar
• Millar WJ, Gerry BH. Childhood Asthma. Health Rep 1998;10:12
   Google Scholar
• Boulet LP, Bai TR, Becker A, et al. What is new since the last (1999) Canadian Asthma Consensus Guidelines? Can Respir J 2001;8 Suppl A:5A-27A
   PubMedGoogle Scholar
• Canadian Lung Association. Medications for Asthma 2011. Available at: http://www lung ca/diseases-maladies/asthma-asthme/treatment-traitement/medications-medicaments_e php [Last accessed 25 January 2011]
   Google Scholar
• Global Initiative for Asthma (GINA), Upated 2012. Global Strategy for Asthma Management and Prevention. Available at: http://www.ginasthma.org/local/uploads/files/GINA_Report_March13.pdf. [Last accessed March 2013]
   Google Scholar
• Chowdhury BA, Dal PG. The FDA and safe use of long-acting beta-agonists in the treatment of asthma. N Engl J Med 2010;362:1169-71.
   PubMed Web of Science ®Google Scholar
• Rodrigo GJ, Castro-Rodriguez JA. Safety of long-acting beta agonists for the treatment of asthma: clearing the air. Thorax 2012;67:342-9.
   PubMed Web of Science ®Google Scholar
• Bateman ED, Hurd SS, Barnes PJ, et al. Global strategy for asthma management and prevention: GINA executive summary. Eur Respir J 2008;31:143-78.
   PubMed Web of Science ®Google Scholar
• Delea TE, Hagiwara M, Stempel DA, Stanford RH. Adding salmeterol to fluticasone propionate or increasing the dose of fluticasone propionate in patients with asthma. Allergy Asthma Proc 2010;31:211-18.
   PubMed Web of Science ®Google Scholar
• Lougheed MD, Lemiere C, Ducharme FM, et al. Canadian Thoracic Society 2012 guideline update: diagnosis and management of asthma in preschoolers, children and adults. Can Respir J 2012;19:127-64.
   PubMed Web of Science ®Google Scholar
• Shahidi N, FitzGerald JM. Current recommendations for the treatment of mild asthma. J Asthma Allergy 2010;3:169-76.
   PubMedGoogle Scholar
• Stanford RH, Fuhlbrigge A, Riedel A, et al. An observational study of fixed dose combination fluticasone propionate/salmeterol or fluticasone propionate alone on asthma-related outcomes. Curr Med Res Opin 2008;24:3141-8.
   PubMed Web of Science ®Google Scholar
• Brixner DI, Lenhart G, Young DC, Samuelson WM. The effect of fixed combination of fluticasone and salmeterol on asthma drug utilization, asthma drug cost, and episodes of asthma exacerbations. Curr Med Res Opin 2007;23:2887-95.
   PubMed Web of Science ®Google Scholar
• Delea TE, Hagiwara M, Stanford RH, Stempel DA. Effects of fluticasone propionate/salmeterol combination on asthma-related health care resource utilization and costs and adherence in children and adults with asthma. Clin Ther 2008;30:560-71.
   PubMed Web of Science ®Google Scholar
• Delea TE, Stanford RH, Hagiwara M, Stempel DA. Association between adherence with fixed dose combination fluticasone propionate/salmeterol on asthma outcomes and costs*. Curr Med Res Opin 2008;24:3435-42.
   PubMed Web of Science ®Google Scholar
• Cerveri I, Locatelli F, Zoia MC, et al. International variations in asthma treatment compliance: the results of the European Community Respiratory Health Survey (ECRHS). Eur Respir J 1999;14:288-94.
   PubMed Web of Science ®Google Scholar
• Horne R. Compliance, adherence, and concordance: implications for asthma treatment. Chest 2006;130:65S-72S.
   PubMed Web of Science ®Google Scholar
• Marceau C, Lemiere C, Berbiche D, et al. Persistence, adherence, and effectiveness of combination therapy among adult patients with asthma. J Allergy Clin Immunol 2006;118:574-81.
   PubMed Web of Science ®Google Scholar
• Présentation de la Régie de l'assurance maladie du Québec. Régie de l'Assurance Maladie du Québec QC. Available at: http://www.ramq.gouv.qc.ca/fr/publications/documents/depliantscitoyens/presentation_regie.pdf. [Last accessed 14 February 2011]
   Google Scholar
• Tamblyn R, Lavoie G, Petrella L, Monette J. The use of prescription claims databases in pharmacoepidemiological research: the accuracy and comprehensiveness of the prescription claims database in Québec. J Clin Epidemiol 1995;48:999-1009.
   PubMed Web of Science ®Google Scholar
• Charlson ME, Pompei P, Ales KL, MacKenzie CR. A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. J Chronic Dis 1987;40:373-83.
   PubMedGoogle Scholar
• D'Hoore W, Bouckaert A, Tilquin C. Practical considerations on the use of the Charlson comorbidity index with administrative data bases. J Clin Epidemiol 1996;49:1429-33.
   PubMed Web of Science ®Google Scholar
• Deyo RA, Cherkin DC, Ciol MA. Adapting a clinical comorbidity index for use with ICD-9-CM administrative databases. J Clin Epidemiol 1992;45:613-19.
   PubMed Web of Science ®Google Scholar
• Maclure M. The case-crossover design: a method for studying transient effects on the risk of acute events. Am J Epidemiol 1991;133:144-53.
   PubMed Web of Science ®Google Scholar
• Suissa S. The case-time-control design. Epidemiology 1995;6:248-53.
   PubMed Web of Science ®Google Scholar
• Blais L, Forget A, Ramachandran S. Acute care among asthma patients using budesonide/formoterol or fluticasone propionate/salmeterol. Respir Med 2009;103:237-43
   PubMed Web of Science ®Google Scholar
• Friedman HS, Navaratnam P, McLaughlin J. Adherence and asthma control with mometasone furoate versus fluticasone propionate in adolescents and young adults with mild asthma. J Asthma 2010;47:994-1000.
   PubMed Web of Science ®Google Scholar
• Steiner JF, Prochazla AV. The assessment of refill compliance using pharmacy records: methods, validity, and applications. J Clin Epidemiol 1997;50:105-16.
   PubMed Web of Science ®Google Scholar
• Stempel DA, Stoloff SW, Carranza R, Jr., et al. Adherence to asthma controller medication regimens. Respir Med 2005;99:1263-7.
   PubMed Web of Science ®Google Scholar
• Stern L, Berman J, Lumry W, et al. Medication compliance and disease exacerbation in patients with asthma: a retrospective study of managed care data. Ann Allergy Asthma Immunol 2006;97:402-8.
   PubMed Web of Science ®Google Scholar
• Stoloff SW, Stempel DA, Meyer J, et al. Improved refill persistence with fluticasone propionate and salmeterol in a single inhaler compared with other controller therapies. J Allergy Clin Immunol 2004;113:245-51.
   PubMed Web of Science ®Google Scholar
• Suissa S, Ernst P, Kezouh A. Regular use of inhaled corticosteroids and the long term prevention of hospitalisation for asthma. Thorax 2002;57:880-4.
   PubMed Web of Science ®Google Scholar
• Williams LK, Pladevall M, Xi H, et al. Relationship between adherence to inhaled corticosteroids and poor outcomes among adults with asthma. J Allergy Clin Immunol 2004;114:1288-93.
   PubMed Web of Science ®Google Scholar
• Williams LK, Peterson EL, Wells K, et al. Quantifying the proportion of severe asthma exacerbations attributable to inhaled corticosteroid nonadherence. J Allergy Clin Immunol 2011;128:1185-91.
   PubMed Web of Science ®Google Scholar
• Baba K, Hattori T, Yagi T, et al. Adherence with long-term asthma management in patients who experienced hospitalized asthma exacerbation. Allergol Int 2009;58:217-24.
   PubMedGoogle Scholar
• Bender BG, Pedan A, Varasteh LT. Adherence and persistence with fluticasone propionate/salmeterol combination therapy. J Allergy Clin Immunol 2006;118:899-904.
   PubMed Web of Science ®Google Scholar
• Bourdin A, Halimi L, Vachier I, et al. Adherence in severe asthma. Clin Exp Allergy 2012;42:1566-74.
   PubMed Web of Science ®Google Scholar
• Colland VT, van Essen-Zandvliet LE, Lans C, et al. Poor adherence to self-medication instructions in children with asthma and their parents. Patient Educ Couns 2004;55:416-21.
   PubMed Web of Science ®Google Scholar
• Hermosa JL, Sanchez CB, Rubio MC, et al. Factors associated with the control of severe asthma. J Asthma 2010;47:124-30.
   PubMed Web of Science ®Google Scholar
• Janson SL, Fahy JV, Covington JK, et al. Effects of individual self-management education on clinical, biological, and adherence outcomes in asthma. Am J Med 2003;115:620-6.
   PubMed Web of Science ®Google Scholar
• Janson SL, McGrath KW, Covington JK, et al. Individualized asthma self-management improves medication adherence and markers of asthma control. J Allergy Clin Immunol 2009;123:840-6.
   PubMed Web of Science ®Google Scholar
• Jochmann A, Scherr A, Jochmann DC, et al. Impact of adherence to the GOLD guidelines on symptom prevalence, lung function decline and exacerbation rate in the Swiss COPD cohort. Swiss Med Wkly 2012;142:w13567.
   PubMed Web of Science ®Google Scholar
• Laforest L, El HA, Pribil C, et al. Asthma patients' self-reported behaviours toward inhaled corticosteroids. Respir Med 2009;103:1366-75.
   PubMed Web of Science ®Google Scholar
• Lasmar L, Camargos P, Champs NS, et al. Adherence rate to inhaled corticosteroids and their impact on asthma control. Allergy 2009;64:784-9.
   PubMed Web of Science ®Google Scholar
• Ohm R, Aaronson LS. Symptom perception and adherence to asthma controller medications. J Nurs Scholarsh 2006;38:292-7.
   PubMed Web of Science ®Google Scholar